Stay updated with breaking news from Markj Foley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Truist Financial reissued their buy rating on shares of Glaukos (NYSE:GKOS – Free Report) in a research report released on Thursday morning, Benzinga reports. Truist Financial currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $120.00. A number of other research firms also recently commented […]
Glaukos Co. (NYSE:GKOS – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $102.60 and last traded at $101.81, with a volume of 32614 shares traded. The stock had previously closed at $101.10. Analyst Ratings Changes A number of analysts have recently commented […]
Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective […]
Robust Sales Drive 40% Quarterly and 77% Annual Revenue Increases
28.02.2024 - Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update. Financial Highlights Total revenue for the fourth quarter 2023 was $69.8 ...